Progression and trajectory network of age-related functional impairments and their associations with mortality: a two-decade prospective study
Hui Chen,Binghan Wang,Rongxia Lv,Tianjing Zhou,Jie Shen,Huan Song,Xiaolin Xu,Yuan Ma,Changzheng Yuan
DOI: https://doi.org/10.1101/2022.08.25.22279239
2022-01-01
Abstract:Objective To characterize the progression and trajectory network of age-related functional impairments and assess their associations with mortality.
Design Prospective cohort study.
Setting The Health and Retirement Study (HRS, 2000-2020).
Participants A total of 17 914 HRS participants aged from 51 to 90 years in 2000.
Main outcome measure Age-related functional impairments including visual impairment, hearing impairment, cognitive impairment, physical frailty, restless sleep, and depression, all measured using structural questionnaires biennially or quadrennially. All-cause mortality was ascertained from multiple sources.
Results During follow-up (median=12 years), the incidence rates of visual impairment (59.3 cases/1000 person years), hearing impairment (52.1 cases/1000 person years), physical frailty (31.7 cases/1000 person years), and cognitive impairment (42.5 cases/1000 person years) increased exponentially with age ( P -trend <0.001), while those of restless sleep (75.6 cases/1000 person years) and depression (35.6 cases/1000 person years) increased relatively slowly. We detected bidirectional associations among all ARFIs ( P <0.001). Overall, each additional ARFI was associated with 13% (11%-15%) higher risk of mortality, with independent associations observed for physical frailty (hazard ratio: 1.59, 95% confidence interval: 1.49-1.69), depression (1.38, 1.30-1.46), visual impairment (1.19, 1.13-1.26), and cognitive impairment (1.13, 1.06-1.21).
Conclusions ARFIs were highly interconnected as a network and were associated with mortality, which highlighted the importance of integrated strategies to monitor and manage the ARFIs to achieve healthy longevity.
WHAT IS ALREADY KNOWN ON THIS TOPIC
WHAT THIS STUDY ADDS
### Competing Interest Statement
The authors have declared no competing interest.
### Funding Statement
This study was funded by Zhejiang University Global Partnership Fund.
### Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used ONLY openly available human data that were originally located at the HRS website (https://hrs.isr.umich.edu/).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
All data produced in the present study are available upon reasonable request to the authors.
* HRS
: Health and Retirement Study
HR
: hazard ratio
CI
: confidence interval
SD
: standard deviation
ARFI
: age-related functional impairment
VI
: visual impairment
HI
: hearing impairment
CI
: cognitive impairment
RS
: restless sleep
PF
: physical frailty